Westside Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $340K | Sell |
6,990
-952
| -12% | -$46.3K | 0.06% | 199 |
|
2025
Q1 | $269K | Buy |
7,942
+1,790
| +29% | +$60.7K | 0.06% | 202 |
|
2024
Q4 | $242K | Sell |
6,152
-290
| -5% | -$11.4K | 0.05% | 210 |
|
2024
Q3 | $308K | Sell |
6,442
-1,021
| -14% | -$48.8K | 0.07% | 187 |
|
2024
Q2 | $403K | Buy |
7,463
+70
| +0.9% | +$3.78K | 0.09% | 156 |
|
2024
Q1 | $504K | Buy |
7,393
+332
| +5% | +$22.6K | 0.12% | 143 |
|
2023
Q4 | $442K | Buy |
7,061
+50
| +0.7% | +$3.13K | 0.11% | 150 |
|
2023
Q3 | $318K | Hold |
7,011
| – | – | 0.09% | 167 |
|
2023
Q2 | $394K | Sell |
7,011
-119
| -2% | -$6.68K | 0.11% | 155 |
|
2023
Q1 | $322K | Sell |
7,130
-600
| -8% | -$27.1K | 0.09% | 169 |
|
2022
Q4 | $27.3K | Hold |
7,730
| – | – | 0.07% | 153 |
|
2022
Q3 | $43.6K | Hold |
7,730
| – | – | 0.1% | 133 |
|
2022
Q2 | $44.1K | Sell |
7,730
-200
| -3% | -$1.14K | 0.1% | 134 |
|
2022
Q1 | $44.1K | Buy |
7,930
+270
| +4% | +$1.5K | 0.1% | 134 |
|
2021
Q4 | $44K | Buy |
7,660
+3,910
| +104% | +$22.4K | 0.1% | 132 |
|
2021
Q3 | $43.8K | Buy |
3,750
+840
| +29% | +$9.81K | 0.1% | 130 |
|
2021
Q2 | $39.3K | Buy |
2,910
+100
| +4% | +$1.35K | 0.09% | 133 |
|
2021
Q1 | $29.6K | Buy |
2,810
+2,510
| +837% | +$26.4K | 0.08% | 132 |
|
2020
Q4 | $30.6K | Sell |
300
-100
| -25% | -$10.2K | 0.08% | 116 |
|
2020
Q3 | $25.1K | Sell |
400
-212
| -35% | -$13.3K | 0.01% | 120 |
|
2020
Q2 | $22.1K | Sell |
612
-250
| -29% | -$9.02K | 0.01% | 103 |
|
2020
Q1 | $25.5K | Buy |
+862
| New | +$25.5K | 0.02% | 112 |
|
2019
Q2 | $4 | Buy |
+100
| New | +$4 | ﹤0.01% | 564 |
|
2018
Q4 | $2.86K | Hold |
100
| – | – | ﹤0.01% | 604 |
|
2018
Q3 | $4.23K | Hold |
100
| – | – | ﹤0.01% | 609 |
|
2018
Q2 | $6.01K | Buy |
+100
| New | +$6.01K | ﹤0.01% | 653 |
|
2018
Q1 | – | Sell |
-100
| Closed | -$2.61K | – | 809 |
|
2017
Q4 | $2.61K | Hold |
100
| – | – | ﹤0.01% | 765 |
|
2017
Q3 | $1.97K | Hold |
100
| – | – | ﹤0.01% | 751 |
|
2017
Q2 | $1.6K | Hold |
100
| – | – | ﹤0.01% | 755 |
|
2017
Q1 | $1.99K | Buy |
+100
| New | +$1.99K | ﹤0.01% | 713 |
|